Novartis counsel warns: ‘Don’t let AI develop without our input’
The best use of AI can—in the most extreme cases—mean the difference between life and death, according to Carol Fang, global head of IP platforms at Novartis.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
30 October 2025 With fraudsters exploiting new technologies, the company’s Kenya Williams explains why vigilant enforcement is money well spent to maintain a ‘clean’ brand.
17 July 2026 This year’s honourees include a firm that has elevated its position to the highest tier with a significant team acquisition—and one that appears in the rankings for the first time.